Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Xtent to liquidate

This article was originally published in The Gray Sheet

Executive Summary

Developer of the Custom NX biolimus A9-eluting stent with adjustable lengths and bioabsorbable polymer plans to liquidate its assets and dissolve the company, subject to shareholder approval, Xtent announces May 15. The firm cited "continued challenges" in the capital markets when it eliminated most of its employees and began looking for buyers in January (1"The Gray Sheet" Feb. 2, 2009, In Brief)

Related Content

Xtent seeks buyer





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts